$NWFL
NORWOOD FINANCIAL CORP

2024 Q2 Form 10-Q Financial Statement

#000156276224000132 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.880M $1.711M
YoY Change 8.92% 2.03%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $344.0K $354.0K
YoY Change -9.47% -6.35%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $12.23M
YoY Change 117.66%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $5.341M $5.608M
YoY Change -35.16% -22.85%
Income Tax $1.128M $1.175M
% Of Pretax Income 21.12% 20.95%
Net Earnings $4.213M $4.433M
YoY Change -35.21% -23.33%
Net Earnings / Revenue 224.1% 259.09%
Basic Earnings Per Share $0.52 $0.55
Diluted Earnings Per Share $0.52 $0.55
COMMON SHARES
Basic Shares Outstanding 8.098M 8.110M
Diluted Shares Outstanding 8.048M 8.070M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $69.40M $112.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.27M $18.06M
YoY Change 5.19% 2.25%
Goodwill $29.27M $29.27M
YoY Change 0.0% 0.0%
Intangibles $183.0K $202.0K
YoY Change -29.62% -28.62%
Long-Term Investments
YoY Change
Other Assets $21.71M $21.64M
YoY Change -6.84% -2.36%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.235B $2.260B
YoY Change 4.37% 7.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.33M $11.74M
YoY Change 87.73% 149.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $62.34M $60.06M
YoY Change -44.49% -44.68%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $75.66M $131.8M
YoY Change -41.53% 16.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.21M $17.24M
YoY Change 5.24% -7.14%
Total Long-Term Liabilities $18.21M $17.24M
YoY Change 5.24% -7.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.66M $131.8M
Total Long-Term Liabilities $18.21M $17.24M
Total Liabilities $2.053B $2.079B
YoY Change 4.31% 7.85%
SHAREHOLDERS EQUITY
Retained Earnings $139.1M $137.3M
YoY Change 2.57% 4.47%
Common Stock $831.0K $831.0K
YoY Change 0.24% 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.977M $5.397M
YoY Change -0.5% 84.2%
Treasury Stock Shares
Shareholders Equity $182.2M $181.2M
YoY Change
Total Liabilities & Shareholders Equity $2.235B $2.260B
YoY Change 4.37% 7.42%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $4.213M $4.433M
YoY Change -35.21% -23.33%
Depreciation, Depletion And Amortization $344.0K $354.0K
YoY Change -9.47% -6.35%
Cash From Operating Activities $9.105M $4.251M
YoY Change 48.77% -57.93%
INVESTING ACTIVITIES
Capital Expenditures $533.0K $554.0K
YoY Change 196.11% 508.79%
Acquisitions
YoY Change
Other Investing Activities -$19.49M -$12.18M
YoY Change -45.44% -77.68%
Cash From Investing Activities -$20.02M -$12.74M
YoY Change -44.21% -76.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -31.65M 54.33M
YoY Change -193.5% 30.28%
NET CHANGE
Cash From Operating Activities 9.105M 4.251M
Cash From Investing Activities -20.02M -12.74M
Cash From Financing Activities -31.65M 54.33M
Net Change In Cash -42.57M 45.84M
YoY Change -1143.33% -1707.96%
FREE CASH FLOW
Cash From Operating Activities $9.105M $4.251M
Capital Expenditures $533.0K $554.0K
Free Cash Flow $8.572M $3.697M
YoY Change 44.31% -63.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001013272
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2024Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-28364
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Norwood Financial Corp
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2828306
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
717 Main Street
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Honesdale
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18431
CY2024Q1 dei City Area Code
CityAreaCode
570
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
253-1455
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.10 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
NWFL
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8098466
CY2024Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
19519000
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
28533000
CY2024Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
92444000
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
37587000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111963000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
398374000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
406259000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18020000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1603428000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2024Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6545000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
7318000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18057000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17838000
CY2024Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
45869000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46439000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
8135000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
8123000
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21642000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21353000
CY2024Q1 us-gaap Goodwill
Goodwill
29266000
CY2023Q4 us-gaap Goodwill
Goodwill
29266000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
202000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
221000
CY2024Q1 us-gaap Other Assets
OtherAssets
16845000
CY2023Q4 us-gaap Other Assets
OtherAssets
13395000
CY2024Q1 us-gaap Assets
Assets
2260423000
CY2023Q4 us-gaap Assets
Assets
2201079000
CY2024Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
383362000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
399545000
CY2024Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1455636000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1395614000
CY2024Q1 us-gaap Deposits
Deposits
1838998000
CY2023Q4 us-gaap Deposits
Deposits
1795159000
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
60055000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74076000
CY2024Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
151179000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
124236000
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11737000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10510000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
17241000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
16028000
CY2024Q1 us-gaap Liabilities
Liabilities
2079210000
CY2023Q4 us-gaap Liabilities
Liabilities
2020009000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8310847
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8310847
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
831000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
831000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97893000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97700000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137285000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
135284000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
200690
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
200690
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5397000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5397000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49399000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47348000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
181213000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181070000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2260423000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2201079000
CY2024Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
23681000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
19158000
CY2024Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2526000
CY2023Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2505000
CY2024Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
731000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
48000
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
26938000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
21711000
CY2024Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
10110000
CY2023Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
4362000
CY2024Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
336000
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
779000
CY2024Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
1782000
CY2023Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
477000
CY2024Q1 us-gaap Interest Expense
InterestExpense
12228000
CY2023Q1 us-gaap Interest Expense
InterestExpense
5618000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14710000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16093000
CY2024Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-624000
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
300000
CY2024Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
15334000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
15793000
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
2000
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
268000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
213000
CY2024Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
151000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
172000
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
2006000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1912000
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6135000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5969000
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
1261000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
1262000
CY2024Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1022000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
768000
CY2024Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
93000
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
161000
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
585000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
285000
CY2024Q1 nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
361000
CY2023Q1 nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
200000
CY2024Q1 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
21000
CY2023Q1 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
29000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2235000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1739000
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
11732000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
10436000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5608000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7269000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1175000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1487000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4433000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5782000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4433000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5782000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2596000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
9355000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-545000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1963000
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
2000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2051000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7390000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2382000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13172000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181070000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4433000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2051000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2432000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
104000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
89000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
181213000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
167085000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5782000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7390000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.29
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2375000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
114000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
334000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
96000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
176415000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
4433000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5782000
CY2024Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-624000
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
300000
CY2024Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
335000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
355000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
256000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-579000
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-71000
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-233000
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2000
CY2024Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
268000
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
213000
CY2024Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-143000
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-129000
CY2024Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
6000
CY2024Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
160000
CY2024Q1 us-gaap Increase Decrease In Loans Held For Sale
IncreaseDecreaseInLoansHeldForSale
-166000
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
89000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
96000
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
104000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
114000
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-284000
CY2024Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
1227000
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
2050000
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1522000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1533000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4251000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10105000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1982000
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
15213000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7824000
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
9996000
CY2024Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1510000
CY2023Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
3685000
CY2024Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
2283000
CY2023Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
3140000
CY2024Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
18172000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
61828000
CY2023Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
2000000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
554000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12736000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54658000
CY2024Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
43839000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
28208000
CY2024Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-14021000
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
15340000
CY2024Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
33057000
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
9811000
CY2024Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
60000000
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
10000000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
334000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2433000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2369000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54328000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41702000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
45843000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2851000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31866000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111963000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29015000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
11001000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
3568000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
257000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
189000
CY2024Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
473000
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
454000
CY2024Q1 us-gaap Dividends Cash
DividendsCash
2432000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
2372000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
139850
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1711000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1677000
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
2000
CY2024Q1 nwfl Loan Servicing Fees
LoanServicingFees
21000
CY2023Q1 nwfl Loan Servicing Fees
LoanServicingFees
20000
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
268000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
213000
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
295000
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
235000
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
2006000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1912000
CY2024Q1 nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8110000
CY2023Q1 nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8176000
CY2024Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
46000
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
45000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8064000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8131000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8064000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8131000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8070000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8148000
CY2024Q1 us-gaap Share Price
SharePrice
27.21
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
110350
CY2023Q1 us-gaap Share Price
SharePrice
29.42
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
89000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
96000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
215725
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.81
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
759000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1500
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.02
CY2024Q1 nwfl Weighted Average Remaining Contractual Term Options Forfeited During Period
WeightedAverageRemainingContractualTermOptionsForfeitedDuringPeriod
P5Y8M12D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
214225
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.77
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
188000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
175725
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.79
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
188000
CY2024Q1 us-gaap Share Price
SharePrice
27.21
CY2023Q4 us-gaap Share Price
SharePrice
32.91
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45966
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.90
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44460
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.12
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45966
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.90
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44460
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.12
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45966
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1253000
CY2024Q1 nwfl Non Vested Restricted Stock Recognition Period
NonVestedRestrictedStockRecognitionPeriod
P4Y9M
CY2024Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
242054000
CY2023Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
274647000
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
8
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
331
CY2023Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
27123000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
26851000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
39706000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
36584000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
72692000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
59464000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
81729000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
69872000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
221250000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
192771000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
240280000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
205603000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
461530000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
398374000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
4000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
2000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
2000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1982000
CY2024Q1 us-gaap Debt Securities
DebtSecurities
380112000
CY2023Q4 us-gaap Debt Securities
DebtSecurities
344204000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1621680000
CY2024Q1 nwfl Percent Of Loans
PercentOfLoans
1.000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1603877000
CY2023Q4 nwfl Percent Of Loans
PercentOfLoans
1.000
CY2024Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
232000
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
259000
CY2024Q1 nwfl Financing Receivable Net Of Deferred Income
FinancingReceivableNetOfDeferredIncome
1621448000
CY2023Q4 nwfl Financing Receivable Net Of Deferred Income
FinancingReceivableNetOfDeferredIncome
1603618000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18020000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1603428000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2024Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3735000
CY2024Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1617945000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1621680000
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7622000
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1596255000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1603877000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
494000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
171000
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-625000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18020000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
69000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
17951000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
364000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
44000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
300000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
19445000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
19444000
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-625000
CY2024Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
3658000
CY2024Q1 nwfl Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
69000
CY2024Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3727000
CY2024Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
8000
CY2024Q1 nwfl Financing Receivable Nonperforming Loans
FinancingReceivableNonperformingLoans
3735000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
7069000
CY2023Q4 nwfl Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
553000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7622000
CY2023Q4 nwfl Financing Receivable Nonperforming Loans
FinancingReceivableNonperformingLoans
7622000
CY2024Q1 nwfl Number Of Loan Modifications Made To Borrowers
NumberOfLoanModificationsMadeToBorrowers
3
CY2024Q1 nwfl Number Of Operating Leases
NumberOfOperatingLeases
7
CY2024Q1 us-gaap Lease Cost
LeaseCost
181000
CY2023Q1 us-gaap Lease Cost
LeaseCost
176000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0258
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
66120000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
1521667000
CY2023Q4 us-gaap Servicing Asset
ServicingAsset
188000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
500000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
680000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
524000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
401000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
401000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2013000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4519000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
637000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3882000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111963000
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
111963000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1603428000
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
1535585000
CY2024Q1 us-gaap Servicing Asset
ServicingAsset
172000
CY2024Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
506000
CY2024Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6545000
CY2024Q1 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
6545000
CY2024Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
45869000
CY2024Q1 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
45869000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
8135000
CY2024Q1 nwfl Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
8135000
CY2024Q1 us-gaap Deposits
Deposits
1838998000
CY2024Q1 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1832638000
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
60055000
CY2024Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
60055000
CY2024Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
151179000
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
150963000
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11737000
CY2024Q1 nwfl Accrued Interest Payable Fair Value Disclosure
AccruedInterestPayableFairValueDisclosure
11737000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2023Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
506000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
7318000
CY2023Q4 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
7318000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46439000
CY2023Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
46439000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
8123000
CY2023Q4 nwfl Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
8123000
CY2023Q4 us-gaap Deposits
Deposits
1795159000
CY2023Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1800104000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74076000
CY2023Q4 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
74076000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
124236000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
124058000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10510000
CY2023Q4 nwfl Accrued Interest Payable Fair Value Disclosure
AccruedInterestPayableFairValueDisclosure
10510000

Files In Submission

Name View Source Status
0001562762-24-000132-index-headers.html Edgar Link pending
0001562762-24-000132-index.html Edgar Link pending
0001562762-24-000132.txt Edgar Link pending
0001562762-24-000132-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwfl-20240331.xsd Edgar Link pending
nwfl-20240331x10q.htm Edgar Link pending
nwfl-20240331xex10_1.htm Edgar Link pending
nwfl-20240331xex31_1.htm Edgar Link pending
nwfl-20240331xex31_2.htm Edgar Link pending
nwfl-20240331xex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
nwfl-20240331_cal.xml Edgar Link unprocessable
nwfl-20240331_def.xml Edgar Link unprocessable
nwfl-20240331_lab.xml Edgar Link unprocessable
nwfl-20240331_pre.xml Edgar Link unprocessable
nwfl-20240331x10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable